These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33968945)

  • 1. Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma.
    Guo M; Ding P; Zhu Z; Fan L; Zhou Y; Yang S; Yang Y; Gu C
    Front Cell Dev Biol; 2021; 9():675939. PubMed ID: 33968945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma.
    Hao R; Hu J; Liu Y; Liang D; Li YM; Wang R; Zhang S; Wang P; Li YJ; Xie S
    Front Oncol; 2021; 11():733175. PubMed ID: 34646775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics and chemical library screens reveal a novel SCF
    Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
    Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RING box protein-1(RBX1), a key component of SCF E3 ligase, induced multiple myeloma cell drug-resistance though suppressing p27.
    Bao E; Zhou Y; He S; Tang J; He Y; Zhu M; Cheng C; Wang Y
    Cancer Biol Ther; 2023 Dec; 24(1):2231670. PubMed ID: 37639640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.
    Zhang Y; Yokoyama S; Herriges JC; Zhang Z; Young RE; Verheyden JM; Sun X
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7557-62. PubMed ID: 27335464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade.
    Zhang J; Su B; Gong C; Xi Q; Chao T
    Biochem Biophys Res Commun; 2016 Sep; 478(1):337-342. PubMed ID: 27422604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma.
    Yao Y; Zhang Y; Shi M; Sun Y; Chen C; Niu M; Zhang Q; Zeng L; Yao R; Li H; Yang J; Li Z; Xu K
    J Leukoc Biol; 2018 Dec; 104(6):1105-1115. PubMed ID: 30024656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance.
    Song Y; Li S; Ray A; Das DS; Qi J; Samur MK; Tai YT; Munshi N; Carrasco RD; Chauhan D; Anderson KC
    Oncogene; 2017 Oct; 36(40):5631-5638. PubMed ID: 28581522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
    Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
    Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis analysis of
    Huang W; Tian X; Guan X
    Transl Cancer Res; 2020 Feb; 9(2):508-521. PubMed ID: 35117395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
    Franke NE; Kaspers GL; Assaraf YG; van Meerloo J; Niewerth D; Kessler FL; Poddighe PJ; Kole J; Smeets SJ; Ylstra B; Bi C; Chng WJ; Horton TM; Menezes RX; Musters RJ; Zweegman S; Jansen G; Cloos J
    Oncotarget; 2016 Nov; 7(46):74779-74796. PubMed ID: 27542283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway.
    Pamarthy D; Tan M; Wu M; Chen J; Yang D; Wang S; Zhang H; Sun Y
    Cancer Biol Ther; 2007 Mar; 6(3):360-6. PubMed ID: 17312389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.
    Narayanan S; Cai CY; Assaraf YG; Guo HQ; Cui Q; Wei L; Huang JJ; Ashby CR; Chen ZS
    Drug Resist Updat; 2020 Jan; 48():100663. PubMed ID: 31785545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gp78 involvement in cellular proliferation: Can act as a promising modulator for cell cycle regulatory proteins?
    Joshi V; Upadhyay A; Chhangani D; Amanullah A; Sharan RN; Mishra A
    J Cell Physiol; 2018 Oct; 233(10):6352-6368. PubMed ID: 29741771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma cells are exceptionally sensitive to heat shock, which overwhelms their proteostasis network and induces apoptosis.
    Sha Z; Goldberg AL
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21588-21597. PubMed ID: 32817432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of PSMB5 on proliferation and bortezomib chemo-resistance in human myeloma cells and its related molecular mechanisms].
    Mo HM; Wu QY; Han DY; Liu R; Ma X; Zhou P; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1053-1057. PubMed ID: 29365400
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma.
    Zang M; Li Z; Liu L; Li F; Li X; Dai Y; Li W; Kuckelkorn U; Doeppner TR; Hermann DM; Zhou W; Qiu L; Jin F
    Cancer Lett; 2015 Oct; 366(2):173-81. PubMed ID: 26116344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.
    Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH
    Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.